EUVIMEDEUVIMED entdecken
Crossref

Assessment of Anti-Inflammatory and Antidiabetic Properties of Selected Ethnomedicinal Herbs used in The Management of Diabetes Mellitus

Irene Ngozi Okafor, Emmanuel Chisom Christopher, Rita Chidimma Egbe

IPS Journal of Biotechnology and Applied Biochemistry · 2026

DOI: 10.54117/ijbab.v2i2.204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IPS Journal of Biotechnology and Applied Biochemistry, 2026. Verfasst von Irene Ngozi Okafor und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study comparatively evaluated the quantitative phytochemical profiles, in vitro antidiabetic activities (α-amylase and α-glucosidase inhibition), and anti-inflammatory potential (bovine serum albumin denaturation inhibition) of aqueous extracts of four key medicinal plants: Vernonia amygdalina, Andrographis paniculata, Ocimum gratissimum, and Momordica charantia. Standard spectrophotometric and titrimetric assays were employed to quantify tannins, phytates, oxalates, alkaloids, and flavonoids. Inhibitory activity against carbohydrate-hydrolyzing enzymes (α-amylase and α-glucosidase) was benchmarked against Acarbose, while anti-inflammatory capacity was benchmarked against Diclofenac sodium using the protein denaturation assay across concentrations of 1 to 5 mg/mL. Phytochemical screening demonstrated high flavonoid levels in O. gratissimum (20.20%) and A. paniculata (15.02%), while high alkaloid levels were present in M. charantia (8.53%) and A. paniculata (7.27%). Anti-nutritional oxalate levels remained safely minimal across all species (0.205–0.292 mg/100g). In carbohydrate-hydrolyzing enzyme assay, V. amygdalina demonstrated superior α-amylase inhibition (IC50 = 1.21 mg/mL, surpassing Acarbose IC50 = 1.28 mg/mL) and potent α-glucosidase inhibition (IC50 = 0.35 mg/mL vs Acarbose IC50 = 0.30 mg/mL). O. gratissimum also exhibited notable α-glucosidase inhibition (IC50 = 2.18 mg/mL Furthermore, in the anti-inflammatory assay, M. charantia (IC50 = 0.43 mg/mL) and V. amygdalina (IC50 = 0.45 mg/mL) exhibited remarkable, superior protection against thermal protein denaturation compared to the standard anti-inflammatory drug Diclofenac sodium (IC50 = 0.88 mg/mL). V. amygdalina and M. charantia possess dual-action antidiabetic and anti-inflammatory properties, providing a strong pharmacological validation for their traditional formulation in managing diabetes mellitus and preventing associated inflammatory complications.

Zitieren

APA

Okafor, I. N., Christopher, E. C., & Egbe, R. C. (2026). Assessment of Anti-Inflammatory and Antidiabetic Properties of Selected Ethnomedicinal Herbs used in The Management of Diabetes Mellitus. IPS Journal of Biotechnology and Applied Biochemistry. https://doi.org/10.54117/ijbab.v2i2.204

Vancouver

Okafor IN, Christopher EC, Egbe RC. Assessment of Anti-Inflammatory and Antidiabetic Properties of Selected Ethnomedicinal Herbs used in The Management of Diabetes Mellitus. IPS Journal of Biotechnology and Applied Biochemistry. 2026. doi:10.54117/ijbab.v2i2.204

BibTeX
@article{Okafor2026,
  author = {Okafor, Irene Ngozi and Christopher, Emmanuel Chisom and Egbe, Rita Chidimma},
  title = {Assessment of Anti-Inflammatory and Antidiabetic Properties of Selected Ethnomedicinal Herbs used in The Management of Diabetes Mellitus},
  journal = {IPS Journal of Biotechnology and Applied Biochemistry},
  year = {2026},
  doi = {10.54117/ijbab.v2i2.204}
}
Kostenlos starten →